Template:Heparin-induced thrombocytopenia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(11 intermediate revisions by 3 users not shown)
Line 2: Line 2:
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
 
<b>
'''Heparin-induced thrombocytopenia Microchapters
Heparin-induced thrombocytopenia
'''
</b>
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
!
Line 11: Line 11:
!
!
[[Heparin-induced thrombocytopenia|Home]]
[[Heparin-induced thrombocytopenia|Home]]
|-
!
|- bgcolor="Pink"
!
[[Heparin-induced thrombocytopenia patient information|Patient Information]]
|-  
|-  
!
!
Line 17: Line 23:
!
!
[[Heparin-induced thrombocytopenia overview|Overview]]
[[Heparin-induced thrombocytopenia overview|Overview]]
|-
!
|- bgcolor="Pink"
!
[[Heparin-induced thrombocytopenia historical perspective|Historical Perspective]]
|-
!
|- bgcolor="Pink"
!
[[Heparin-induced thrombocytopenia classification|Classification]]
|-  
|-  
!
!
Line 28: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Heparin-induced thrombocytopenia epidemiology and demographics|Epidemiology and demographics]]
[[Heparin-induced thrombocytopenia causes|Causes]]
|-  
|-  
!
!
Line 34: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Heparin-induced thrombocytopenia classification|Classification]]
[[Heparin-induced thrombocytopenia differential diagnosis|Differentiating Heparin-induced thrombocytopenia from other Diseases]]
|-
!
 
|- bgcolor="Pink"
!
[[Heparin-induced thrombocytopenia epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 46: Line 70:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Heparin-induced thrombocytopenia differential diagnosis|Differentiating Heparin-induced thrombocytopenia from other Disaeses]]
[[Heparin-induced thrombocytopenia screening|Screening]]
|-
!
 
|- bgcolor="Pink"
!
[[Heparin-induced thrombocytopenia natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 52: Line 82:
|- bgcolor="CornFlowerBlue"
|- bgcolor="CornFlowerBlue"
!
!
[[Heparin-induced thrombocytopenia diagnosis|Diagnosis]]
Diagnosis
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia diagnostic criteria|Diagnostic Criteria]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia history and symptoms|History and Symptoms]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia physical examination|Physical Examination]]
|-  
|-  
!
!
Line 58: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Heparin-induced thrombocytopenia history and symptoms|History & Symptoms]]
[[Heparin-induced thrombocytopenia laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 64: Line 112:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Heparin-induced thrombocytopenia lab tests | Lab tests]]
[[Heparin-induced thrombocytopenia electrocardiogram|Electrocardiogram]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia chest x ray|Chest X Ray]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia echocardiography and ultrasound|Echocardiography and Ultrasound]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia CT|CT]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia MRI|MRI]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia other imaging findings|Other Imaging Findings]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Heparin-induced thrombocytopenia other diagnostic studies|Other Diagnostic Studies]]
|-  
|-  
!
!
Line 70: Line 154:
|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"
!
!
[[Heparin-induced thrombocytopenia treatment|Treatment]]
Treatment
|-  
|-  
!
!
Line 77: Line 161:
!
!
[[Heparin-induced thrombocytopenia medical therapy|Medical Therapy]]
[[Heparin-induced thrombocytopenia medical therapy|Medical Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia primary prevention|Primary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia secondary prevention|Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia future or investigational therapies|Future or Investigational Therapies]]
|-
!
|- bgcolor="CadetBlue"
!
Case Studies
|-
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia case study one|Case #1]]
|-  
|-  
!
!
Line 171: Line 291:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small>
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]
|-  
|-  
!  
!  

Latest revision as of 16:45, 2 August 2018